Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for Trichuris trichiura infection
ISRCTN15871729Phase 2Completed
- Sponsor
- Swiss Tropical and Public Health Institute
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ivermectin in trichuriasis (5 arms), sponsored by Swiss Tropical and Public Health Institute. Primary endpoint: Cure rate for Trichuris infection. Started May 2017; status: completed.
02
Drugs
ivermectin
03
Conditions
trichuriasis
Beyond the preview
Go deeper on ISRCTN15871729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15871729.